{"id":19983,"date":"2019-01-16T12:18:04","date_gmt":"2019-01-16T12:18:04","guid":{"rendered":"https:\/\/arisglobal.com\/bkp-site\/?p=19983"},"modified":"2019-01-16T12:18:04","modified_gmt":"2019-01-16T12:18:04","slug":"convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers","status":"publish","type":"post","link":"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/","title":{"rendered":"Convergence of Local &#038; Global Pharmacovigilance Regulations in China for Drug Manufacturers"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>With the recent string of regulatory reforms and NMPA joining ICH, China is poised to catch-up with the leading health authorities in bringing high-quality, low-cost, innovative medicines to its population and ensuring<\/p>\n","protected":false},"author":27,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-19983","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.4 (Yoast SEO v23.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Convergence of Local &amp; Global Pharmacovigilance Regulations in China for Drug Manufacturers | ArisGlobal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Convergence of Local &amp; Global Pharmacovigilance Regulations in China for Drug Manufacturers\" \/>\n<meta property=\"og:description\" content=\"With the recent string of regulatory reforms and NMPA joining ICH, China is poised to catch-up with the leading health authorities in bringing high-quality, low-cost, innovative medicines to its population and ensuring\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/\" \/>\n<meta property=\"og:site_name\" content=\"ArisGlobal\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LifeSphereAG\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-16T12:18:04+00:00\" \/>\n<meta name=\"author\" content=\"Mladen Prenc\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mladen Prenc\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/\"},\"author\":{\"name\":\"Mladen Prenc\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974\"},\"headline\":\"Convergence of Local &#038; Global Pharmacovigilance Regulations in China for Drug Manufacturers\",\"datePublished\":\"2019-01-16T12:18:04+00:00\",\"dateModified\":\"2019-01-16T12:18:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/\"},\"wordCount\":11,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.arisglobal.com\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/\",\"url\":\"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/\",\"name\":\"Convergence of Local & Global Pharmacovigilance Regulations in China for Drug Manufacturers | ArisGlobal\",\"isPartOf\":{\"@id\":\"https:\/\/www.arisglobal.com\/#website\"},\"datePublished\":\"2019-01-16T12:18:04+00:00\",\"dateModified\":\"2019-01-16T12:18:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.arisglobal.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Convergence of Local &#038; Global Pharmacovigilance Regulations in China for Drug Manufacturers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arisglobal.com\/#website\",\"url\":\"https:\/\/www.arisglobal.com\/\",\"name\":\"ArisGlobal\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.arisglobal.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arisglobal.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.arisglobal.com\/#organization\",\"name\":\"LifeSphere\",\"url\":\"https:\/\/www.arisglobal.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"LifeSphere\"},\"image\":{\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LifeSphereAG\/\",\"https:\/\/www.linkedin.com\/products\/aris-global-lifesphere\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974\",\"name\":\"Mladen Prenc\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Convergence of Local & Global Pharmacovigilance Regulations in China for Drug Manufacturers | ArisGlobal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/","og_locale":"en_US","og_type":"article","og_title":"Convergence of Local & Global Pharmacovigilance Regulations in China for Drug Manufacturers","og_description":"With the recent string of regulatory reforms and NMPA joining ICH, China is poised to catch-up with the leading health authorities in bringing high-quality, low-cost, innovative medicines to its population and ensuring","og_url":"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/","og_site_name":"ArisGlobal","article_publisher":"https:\/\/www.facebook.com\/LifeSphereAG\/","article_published_time":"2019-01-16T12:18:04+00:00","author":"Mladen Prenc","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mladen Prenc"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/#article","isPartOf":{"@id":"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/"},"author":{"name":"Mladen Prenc","@id":"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974"},"headline":"Convergence of Local &#038; Global Pharmacovigilance Regulations in China for Drug Manufacturers","datePublished":"2019-01-16T12:18:04+00:00","dateModified":"2019-01-16T12:18:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/"},"wordCount":11,"commentCount":0,"publisher":{"@id":"https:\/\/www.arisglobal.com\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/","url":"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/","name":"Convergence of Local & Global Pharmacovigilance Regulations in China for Drug Manufacturers | ArisGlobal","isPartOf":{"@id":"https:\/\/www.arisglobal.com\/#website"},"datePublished":"2019-01-16T12:18:04+00:00","dateModified":"2019-01-16T12:18:04+00:00","breadcrumb":{"@id":"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.arisglobal.com\/uncategorized\/convergence-of-local-global-pharmacovigilance-regulations-in-china-for-drug-manufacturers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.arisglobal.com\/"},{"@type":"ListItem","position":2,"name":"Convergence of Local &#038; Global Pharmacovigilance Regulations in China for Drug Manufacturers"}]},{"@type":"WebSite","@id":"https:\/\/www.arisglobal.com\/#website","url":"https:\/\/www.arisglobal.com\/","name":"ArisGlobal","description":"","publisher":{"@id":"https:\/\/www.arisglobal.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arisglobal.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.arisglobal.com\/#organization","name":"LifeSphere","url":"https:\/\/www.arisglobal.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"LifeSphere"},"image":{"@id":"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LifeSphereAG\/","https:\/\/www.linkedin.com\/products\/aris-global-lifesphere\/"]},{"@type":"Person","@id":"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974","name":"Mladen Prenc"}]}},"_links":{"self":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts\/19983"}],"collection":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/comments?post=19983"}],"version-history":[{"count":0,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts\/19983\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/media?parent=19983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/categories?post=19983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/tags?post=19983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}